We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Inspections and Audits » The Inextricable Link Between Data Integrity and Quality Culture – Webinar Recording/Transcript

Other Options

Webinar Recording & Transcript Bundle - Feb. 9, 2023

$287.00

Webinar Recording & Transcript Bundle - Feb. 9, 2023

$258.00

Webinar Recording & Transcript Bundle - Feb. 9, 2023

$244.00

Webinar Recording & Transcript Bundle - Feb. 9, 2023

$230.00

Webinar Recording & Transcript Bundle - Feb. 9, 2023

$215.00
Kara-Stockett-Quinn-500aqua.jpg

The Inextricable Link Between Data Integrity and Quality Culture – Webinar Recording/Transcript

$287.00
Quality

Product Details

Quality culture, quality by design, data integrity — these are more than mere buzzwords. They are the backbone of good manufacturing practice (GMP) and they are inextricably linked, especially in the eyes of the FDA and other regulators. But everyone seems to have a different idea of what these terms mean and how they fit together.

Can you have a culture of quality without strong data integrity protections? Probably not. Does data integrity make a quality culture by itself? No. Is everyone in your organization responsible for setting and maintaining a culture of quality? Absolutely.

In this presentation, industry thought leader Kara Quinn dives deep into the concept of  quality culture and the role data integrity plays in it. She explores how  different stakeholders in an organization contribute to the culture. She  explains how quality culture needs to start at the top with executive  leadership promoting and committing to the concept and then filter all the way  through a company so that everyone understands what it means, how important it  is and how they can contribute to it.

Presentation Takeaways:

  • How the FDA measures quality culture through the lens of warning letters citing data integrity failures
  • FDA inspection trends related to quality and data integrity
  • How to comply with the FDA’s guidance on data integrity by taking a back-to-basics approach
  • How to differentially apply FDA’s guidance to electronic vs. paper-based systems
  • How to develop a world-class quality culture incorporating realistic performance outcomes and transparency
  • How to develop and implement best practices in right-first-time data capture and continuous data integrity verification, such as quality-by-design and quality risk management
  • How to overcome the practical challenges to data integrity and quality culture integration, including human nature and leadership behaviors

Quality culture and data integrity shouldn’t be just lofty goals; they need to be a matter of everyday practice.

Meet Your Presenter

Kara Stockett Quinn's most recent position was as a senior consultant with ValSource Consulting. Prior to consulting, Ms. Quinn was employed with Merck & Co., Inc. for 28 years providing process technical and quality systems support across the small and large molecule product portfolios. Ms. Quinn has a broad range of end-to-end pharmaceutical experience having held positions supporting non-clinical and clinical investigations, clinical development, process scale-up and technology transfer, facility and process validation, commercialization and licensing, PAIs, and quality management systems support for market supply. In recent years Ms. Quinn honed her skills as a subject matter expert in the fit-for-function qualification of bio/pharmaceutical raw materials and novel excipients. She led a team of industry peers in the development and publication of a practical tool for raw material risk assessments.

Who Will Benefit

  • Quality assurance professionals (all levels)
  • Quality control professionals (all levels)
  • Operations personnel (all levels)

Webinar Recording & Transcript Bundle

$287.00
Add to Cart

Webinar date:
Feb. 9, 2023

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing